ZOLL TherOx

ZOLL® TherOx is on a mission to improve outcomes and help save more lives through SSO2 therapy.

[ZOLL TherOx @ZOLLTherOx]

Why completing reperfusion in the Cath Lab matters to advancing STEMI Care?

Dr. Rajiv Jauhar @stendoc1 discusses the importance of addressing not only epicardial flow, but also microvascular flow in #STEMI to address the entire coronary circulation.

See IFU: https://t.co/PCPujRQAd1

[ZOLL TherOx @ZOLLTherOx]

What can Interventional Cardiologists do to prevent #MVO at the time of PCI and preserve ejection fraction?

“Achieving epicardial patency w/ short DTB times is something we have done very well. But we don’t achieve actual [myocardial] tissue perfusion,” – explains Dr. Michael Lim in his #CRT26 presentation.

Learn how achieving #completereperfusion w/ SSO2 Therapy can help LAD #STEMI patients.

See IFU: https://t.co/PCPujRQAd1

[ZOLL TherOx @ZOLLTherOx]

Epicardial reperfusion (TIMI 3 flow) is necessary, but not sufficient. 1 in 4 STEMI patients are at risk of developing heart failure w/n 3 mo of PCI: https://t.co/Np3f581MrS

At TherOx, we are committed to Doing More for #STEMI. Our SSO2 Therapy rapidly restores microvascular flow via diffusive effect of super-oxygenated plasma, reperfusing ischemic myocardium to minimize infarct size.

Infarct size is an independent predictor of death & #heartfailure at 1 YR in STEMI: https://t.co/oZcMurIJSH

Thank you Drs. Marcus St John, Carlos E Alfonso, MD Sheng Fu, Alvaro Gomez, and Miami @BaptistHealthSF for hosting and joining us in our commitment to Do More for STEMI patients.
2/2

[ZOLL TherOx @ZOLLTherOx]

Congratulations to the newest group of SSO2 Therapy Super Users! This incredible team has completed our hands-on training for the FDA-approved SuperSaturated Oxygen (SSO2) Therapy to complete the reperfusion in LAD #STEMI patients post-PCI.

🎯 Completing the Reperfusion focuses on successfully restoring blood flow from the epicardial arteries to the most distal myocardial tissue through restoration of microvascular flow post-PCI.

Complete the Reperfusion 🫀 = Epicardial Reperfusion + Microvascular Reperfusion

See IFU: https://t.co/PCPujRR82z
1/2

[ZOLL TherOx @ZOLLTherOx]

Standing room only at #SCAI2026 Symposium: The New Era of Myocardial Perfusion in STEMI.

What are the key takeaways from the symposium?

➡️Epicardial reperfusion (TIMI 3 flow) is necessary but not sufficient. Opening the artery is not the same as restoring the myocardium.

➡️ #STEMI outcomes are not defined by DTB times alone. Time to Myocardial Protection matters.

➡️To change outcomes in STEMI, treat the microvasculature, not just epicardial artery - @FarazHaroonMD

🎯Complete the Reperfusion: Epicardial Reperfusion + Microvascular Reperfusion 🫀

SSO2 Therapy targets the microvasculature through its MOA: (Kloner et al: https://t.co/MeIv6q2bDo)

SSO2 Therapy has been shown to reduce infarct size & relieve MVO post-PCI in LAD STEMI w/o impacting DTB times: https://t.co/9nzLEP9LHh

Learn more at https://t.co/7XmfyOHrSP

See IFU: https://t.co/PCPujRQAd1

[Apurva Sharma @dr_sapurva]

STEMI management in 2026 …. Complete reperfusion is beyond TIMi 3 flow .. with the real target being MVO and reducing ischemia !! Excellent session @SCAI @SrihariNaiduMD @HaroonFarazMD @SandeepNathanMD

[Srihari S. Naidu, MD @SrihariNaiduMD]

Packed room at #SCAI2026 @SCAI to discuss complete reperfusion during primary STEMI PCI @SandeepNathanMD @HaroonFarazMD @mjlimmd @ZOLLTherOx

[ZOLL TherOx @ZOLLTherOx]

Today at #SCAI2026: Don’t miss our lunch symposium at 11:55am in Room 510B to learn why achieving #completereperfusion post-PCI in LAD #STEMI patients is the new era for Interventional Cardiologists to advance STEMI care and improve prognosis.

See IFU: https://t.co/MCMuUv5mjw

[ZOLL TherOx @ZOLLTherOx]

Early infarct size is a predictor of death or #heartfailure hospitalization w/in 1YR after primary PCI for #STEMI patients: https://t.co/oZcMurIJSH

SSO2 Therapy has been shown to reduce infarct size post-PCI in LAD STEMI w/o impacting DTB times: https://t.co/9nzLEP9LHh

➡️ Visit Zoll TherOx Booth 316 at #SCAI2026 today to learn about SSO2 Therapy and Completing the Reperfusion to advance STEMI care.

See IFU: https://t.co/PCPujRQAd1

[ZOLL TherOx @ZOLLTherOx]

#SCAI2026 kicks off today in Montreal, Canada. Advancing STEMI care is on the agenda – join our lunch symposium about Completing the Reperfusion in #STEMI on Saturday, April 25 at 11:55am in Room 510B.

➡️Visit Zoll Booth 316 to learn how SSO2 Therapy can support your LAD STEMI patients post-PCI.

See IFU: https://t.co/PCPujRQAd1

[ZOLL TherOx @ZOLLTherOx]

What’s on your agenda for #SCAI2026?

Don’t miss our lunch symposium “Complete the Reperfusion. The New Era of Complete Myocardial Perfusion in #STEMI” moderated by Dr. Tim Henry & @drmeghaprasad

🗓️Saturday, April 25
🕛11:55 -12:55 PM EST
📍Room 510 B

[ZOLL TherOx @ZOLLTherOx]

#SCAI2026 is just 10 days away.
🗓️Mark your calendar for our lunch symposium on advancing #STEMI care: "Complete the Reperfusion The New Era of Myocardial Perfusion in STEMI" with the esteemed faculty @SandeepNathanMD @SrihariNaiduMD @drmeghaprasad @HaroonFarazMD @gauravraomd Tim Henry, William O’Neill & Michael Lim

See IFU: https://t.co/PCPujRR82z

[ZOLL TherOx @ZOLLTherOx]

What is Complete Reperfusion in #STEMI and how does it impact Interventional Cardiologists performing PCIs? - @SandeepNathanMD explains.

#CompleteReperfusion 🫀= Epicardial Reperfusion + Microvascular Reperfusion

[ZOLL TherOx @ZOLLTherOx]

Visit us at #ACC26 in Booth 2437 to learn how SSO2 Therapy can support your LAD #STEMI patients.

✅ SSO2 Therapy is the only FDA-approved therapy shown to reduce infarct size & relieve MVO post-PCI: https://t.co/MeIv6q2bDo

STEMI patients need restoration of both epicardial and microvascular patency to complete reperfusion post-PCI to impact prognosis: https://t.co/KibSugScVi

Doing More for STEMI patients starts in the Cath Lab.

Epicardial Reperfusion + Microvascular Reperfusion= #CompleteReperfusion🫀

See IFU: https://t.co/PCPujRQAd1

[ZOLL TherOx @ZOLLTherOx]

✅SSO2 Therapy is a cost-effective from the perspective of the US healthcare system for LAD STEMI patients undergoing pPCI w/n 6 hours of symptoms onset as shown in Dr. Cohen’s analysis based on disease-simulation model.

4/4

[ZOLL TherOx @ZOLLTherOx]

What are the key takeaways for you from #CRT2026?
We are inspired to see more conversations focused on doing more for #STEMI patients in the Cath lab.

PCI alone is not enough—we are still seeing high rates of #heartfailure despite successful epicardial reperfusion.

STEMI patients need #CompleteReperfusion ➡️ restoring both epicardial & microvascular flow to improve the prognosis https://t.co/MeIv6q2bDo

See IFU: https://t.co/PCPujRQAd1
1/4

[ZOLL TherOx @ZOLLTherOx]

✅SSO2 Therapy has shown to reduce #MVO by rapidly increasing microvascular blood flow with its MOA https://t.co/tOdsd9NSmO

3/4